NAMS · Forms 3, 4, 5

Insider trades at NewAmsterdam Pharma Co N.V.

1 insider sold $1.3M of NewAmsterdam Pharma Co N.V. stock on the open market in the last 30 days.

Every Form 3, 4 and 5 filed for NewAmsterdam Pharma Co N.V. (NAMS) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.

Insider trades in the last 90 days

DateInsiderRoleTransactionSharesPriceValueFiling
Johannes Jacob Pieter KasteleinChief Scientific OfficerOption exercise50,246Form 4
Johannes Jacob Pieter KasteleinChief Scientific OfficerSell50,246$25.03$1.3MForm 4
Michael H. DavidsonChief Executive OfficerBuy10,000$22.65$227KForm 4
John W SmitherDirectorSell1,600$25.32$41KForm 4
Robert William GunningVice President, ControllerAward3,200Form 4
Johannes Jacob Pieter KasteleinChief Scientific OfficerOption exercise125,000Form 4
Johannes Jacob Pieter KasteleinChief Scientific OfficerSell125,000$26.91$3.4MForm 4
Robert William GunningVice President, ControllerBecame an insider (Form 3)Form 3
Louise Frederika KooijChief Accounting OfficerOption exercise25,000$11.90$298KForm 4
Louise Frederika KooijChief Accounting OfficerOption exercise80,000$11.17$894KForm 4
Louise Frederika KooijChief Accounting OfficerSell70,200$29.96$2.1MForm 4
Louise Frederika KooijChief Accounting OfficerSell31,885$31.05$990KForm 4
Louise Frederika KooijChief Accounting OfficerSell2,915$31.71$92KForm 4

Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.